Unique ID issued by UMIN | UMIN000032554 |
---|---|
Receipt number | R000036994 |
Scientific Title | Prostate Cancer Lesion Targeted Cryoablation: Investigator Initiated Trial |
Date of disclosure of the study information | 2018/09/01 |
Last modified on | 2023/05/31 12:18:46 |
Prostate Cancer Lesion Targeted Cryoablation: Investigator Initiated Trial
Procry
Prostate Cancer Lesion Targeted Cryoablation: Investigator Initiated Trial
Procry
Japan |
Localized prostate cancer
Urology |
Malignancy
NO
To demonstrate the effecacy and safety of targeted focal cryotherapy using Visual ICE for the localized prostate cancer patient with single focus of biopsy-proven MRI-visible clinically significant cancer
Others
To demonstrate efficacy and safety of minimally invasive therapeutic option of targeted focal cryoablation to achieve cancer controle and maintaining of quality-of-life
Others
Others
Not applicable
To achieve all of these 1),2), and 3):
1) 50% or greater in PSA dicrease rate from pre-op PSA to post-op PSA at post-op 3 or 6 months
2) 3 or less in PI-RADS actogry of the targeted MRI-lesion at post-op 6 months
3) Negative for cancer in the targeted prostate biopsies at post-op 6 months from the treated targeted-lesion
Patient reported quality-of-life by EPIC and EQ5D questionnaires
PSA change
PI-RADS category change
Prostate biopsy outcome (focused on Gleason score)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Device,equipment |
Percutaneous cryosurgery to target the prostate cancer lesion
50 | years-old | <= |
85 | years-old | >= |
Male
1) MRI-visible single focus clinically significant cancer proven by prostate biopsy
2) T2a-T2cN0M0
3) Men aged 20-85
4) Men with informed consent
1) MRI-visible biopsy proven cancer with both Gleason 6 and PI-RADS catogry 3 or with both Gleason 8 and PI-RADS catogory 5
2) PSA >20ng/ml
3) 5mm or less in distance between cancer lesion and urethral sphinctre muscle
4) Any treatment for prostate cancer in the past
5) Any anti-androgen therapy for BPH
6) Patient who use pad for urinary incontinence
7) Active cancer in other organ
8) Patient who cannot undergo MRI-prostate
9) Difficulty of undergoing transrectal ultrasonography
10) Prothrombin time<50% or platelet count <<60,000/mm3
11) Attending physician determines that the ineligible
50
1st name | Osamu |
Middle name | |
Last name | Ukimura |
Kyoto Prefectural Univeristy of Medicine
Urology
602-8566
Kawaramachi-Hirokoji, Kyoto, 602-8566
0752515595
ukimura@koto.kpu-m.ac.jp
1st name | Osamu |
Middle name | |
Last name | Ukimura |
Kyoto Prefectural University of Medicine
Urology
602-8566
Kawaramachi-Hirokoji, Kyoto, 602-8566
0752515595
https://www.KPUM-urology.com
ukimura@koto.kpu-m.ac.jp
Kyoto Prefectural University of Medicine
Japan Agency for Medical Research and Development
Other
Japan
Kyoto Min-iren Cyuo Hospital
Kyoto Prefectural University of Medicine IRB
Kawamachi-Hirokoji, Kajiicyou 465, Kyoto, Japan
075-251-5595
rinri@koto.kpu-m.ac.jp
YES
jRCT2052210088
Japan Registry of Clinical Trials
有り
京都府立医科大学附属病院 および 京都民医連中央病院
2018 | Year | 09 | Month | 01 | Day |
Unpublished
51
No longer recruiting
2018 | Year | 09 | Month | 01 | Day |
2021 | Year | 08 | Month | 05 | Day |
2021 | Year | 10 | Month | 11 | Day |
2024 | Year | 02 | Month | 28 | Day |
This investigator initiated clinical trial has been published in jR CT (Japan Registry of Clinical Trials https://jrct.niph.go.jp) as the number of jRCT2052210088 (PROCRY) with some modifications from the contents of this page.
Date of First Enrollment: 2021/10/11
Sample Size: n=50
2018 | Year | 05 | Month | 11 | Day |
2023 | Year | 05 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036994
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |